Fibrobiologics Inc (FBLG) Stock Price, Quote & News

Company Profile

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Industry: Biotechnology

Sector: Healthcare

Phone: 281-651-5150

Website: www.fibrobiologics.com

Address:

455 East Medical Center Boulevard, Suite 300, Houston, United States

derider58 Sep. 12 at 3:03 PM

$FBLG I think it's time for a rebound!

0 · Reply

JarvisFlow Sep. 12 at 10:30 AM

HC Wainwright & Co. has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 10.

0 · Reply

RunnerSignals Sep. 11 at 9:05 PM

Upgrade Parade 2/2 $FBLG $HPE $NVDA $RNA all got upgraded today! https://stocksrunner.com/news/2025-09-11-top-stock-upgrades-today-avgo-baba-chwy-etn-fblg-hpe-nvda-rna

0 · Reply

MrTicker Sep. 11 at 6:43 PM

$FBLG solid PR's the past week. Hasn't been noticed yet. Still due for a run. $PFSA foundation around .45 , broke .50 a few times and retraced, could see some upward action to force covers above .55 during power hour , $DVLT .34 consolidation, watching for a break above .38 for new high of day..

0 · Reply

MrTicker Sep. 11 at 2:16 PM

$FBLG BRIEF-Fibrobiologics Announces Positive IND-Enabling Updates Demonstrating Potential Of Fibroblast Spheroids In Chronic-Relapse Psoriasis Treatment REUTERS 9:09 AM ET 9/11/2025

0 · Reply

ZacksSCR Sep. 10 at 5:46 PM

$FBLG: Advancing Bone Marrow Organoid Platform for Cancer and Immune-Related Therapies… https://buff.ly/cEBFK7e

0 · Reply

Cookem_up09 Sep. 10 at 5:25 PM

$FBLG https://www.stocktitan.net/news/FBLG/fibro-biologics-announces-significant-advancements-in-bone-marrow-8hjln9xsajjh.html

0 · Reply

prismmarketview Sep. 10 at 3:39 PM

(NASDAQ: $FBLG) FibroBiologics advances its Bone Marrow Organoid platform, showing tumor reduction in melanoma models. Tech enables gene editing, cryopreservation & immune cell regeneration—with potential for in vivo CAR-T & CAR-NK therapies. https://prismmarketview.com/fibrobiologics-advances-bone-marrow-organoid-platform-with-potential-in-cancer-and-immune-therapies/

0 · Reply

MrTicker Sep. 10 at 3:18 PM

$FBLG D. Boral Capital Maintains Buy on FibroBiologics, Maintains $16 Price Target BENZINGA 10:18 AM ET 9/10/2025

0 · Reply

derider58 Sep. 10 at 1:27 PM

$FBLG

0 · Reply

FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies

Sep 11, 2025, 8:30 AM EDT - 5 days ago

FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment

Sep 10, 2025, 8:30 AM EDT - 6 days ago

FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

Aug 27, 2025, 8:30 AM EDT - 20 days ago

FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Jul 31, 2025, 4:30 PM EDT - 6 weeks ago

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jul 28, 2025, 8:30 AM EDT - 7 weeks ago

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

Jul 11, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics to Present at the Advanced Wound Care Summit USA

Jul 9, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

Jul 7, 2025, 4:35 PM EDT - 2 months ago

FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

Jun 16, 2025, 4:35 PM EDT - 3 months ago

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

Jun 16, 2025, 9:50 AM EDT - 3 months ago

FibroBiologics to Present at the BIO International Convention 2025

Jun 9, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

May 16, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

May 14, 2025, 4:30 PM EDT - 4 months ago

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 29, 2025, 9:15 AM EDT - 5 months ago

FibroBiologics Presenting at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 5 months ago

FibroBiologics Presents at the ThymUS 2025 Meeting

Apr 11, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

Apr 8, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Apr 2, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

Mar 31, 2025, 4:25 PM EDT - 6 months ago

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 27, 2025, 8:30 AM EDT - 6 months ago

FibroBiologics Announces 2025 Annual Meeting of Stockholders

Mar 21, 2025, 8:30 AM EDT - 6 months ago

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

Mar 4, 2025, 8:30 AM EST - 7 months ago

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Feb 27, 2025, 8:30 AM EST - 7 months ago

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Feb 5, 2025, 9:15 AM EST - 7 months ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

Dec 30, 2024, 4:30 PM EST - 9 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Dec 30, 2024, 2:12 PM EST - 9 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Dec 23, 2024, 7:55 AM EST - 9 months ago

FibroBiologics Announces $25 Million Financing

Nov 19, 2024, 9:15 AM EST - 10 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 14, 2024, 9:15 AM EST - 10 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Nov 12, 2024, 4:20 PM EST - 10 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 29, 2024, 9:15 AM EDT - 11 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 28, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

Oct 18, 2024, 8:30 AM EDT - 11 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 16, 2024, 9:15 AM EDT - 11 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

Oct 11, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

Sep 30, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

Sep 19, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Engages Southern Star Research as CRO in Australia

Sep 12, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

Sep 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 20, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Aug 7, 2024, 6:52 PM EDT - 1 year ago

FibroBiologics Files 2024 Second Quarter Report

Jul 15, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

Jun 25, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Set to Join Russell 2000® Index

Jun 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 14, 2024, 5:24 PM EDT - 1 year ago

FibroBiologics Files 2024 First Quarter Report

May 7, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the BIO International Convention 2024

Apr 11, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

derider58 Sep. 12 at 3:03 PM

$FBLG I think it's time for a rebound!

0 · Reply

JarvisFlow Sep. 12 at 10:30 AM

HC Wainwright & Co. has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 10.

0 · Reply

RunnerSignals Sep. 11 at 9:05 PM

Upgrade Parade 2/2 $FBLG $HPE $NVDA $RNA all got upgraded today! https://stocksrunner.com/news/2025-09-11-top-stock-upgrades-today-avgo-baba-chwy-etn-fblg-hpe-nvda-rna

0 · Reply

MrTicker Sep. 11 at 6:43 PM

0 · Reply

MrTicker Sep. 11 at 2:16 PM

$FBLG BRIEF-Fibrobiologics Announces Positive IND-Enabling Updates Demonstrating Potential Of Fibroblast Spheroids In Chronic-Relapse Psoriasis Treatment REUTERS 9:09 AM ET 9/11/2025

0 · Reply

ZacksSCR Sep. 10 at 5:46 PM

$FBLG: Advancing Bone Marrow Organoid Platform for Cancer and Immune-Related Therapies… https://buff.ly/cEBFK7e

0 · Reply

Cookem_up09 Sep. 10 at 5:25 PM

$FBLG https://www.stocktitan.net/news/FBLG/fibro-biologics-announces-significant-advancements-in-bone-marrow-8hjln9xsajjh.html

0 · Reply

prismmarketview Sep. 10 at 3:39 PM

0 · Reply

MrTicker Sep. 10 at 3:18 PM

$FBLG D. Boral Capital Maintains Buy on FibroBiologics, Maintains $16 Price Target BENZINGA 10:18 AM ET 9/10/2025

0 · Reply

derider58 Sep. 10 at 1:27 PM

$FBLG

0 · Reply

MrTicker Sep. 10 at 12:39 PM

$FBLG Sept 10 (Reuters) - Fibrobiologics Inc(FBLG): * FIBROBIOLOGICS ANNOUNCES SIGNIFICANT ADVANCEMENTS IN BONE MARROW ORGANOID PLATFORM ENABLING DEVELOPMENT FOR CANCER AND IMMUNE-RELATED THERAPIES * FIBROBIOLOGICS(FBLG): BONE MARROW ORGANOIDS TRANSPLANTATION INTO MELANOMA MOUSE MODEL REDUCES TUMOR SIZE Source text: Further company coverage:

0 · Reply

MrTicker Sep. 10 at 12:35 PM

$FBLG FibroBiologics Advances Bone Marrow Organoid Platform Offering New Treatment Options For Hematopoietic Cancers And Age-Related Immune Decline BENZINGA 7:35 AM ET 9/10/2025

0 · Reply

MrTicker Sep. 10 at 12:32 PM

$FBLG https://ml.globenewswire.com/media/N2MxZjYxZjUtMmQ5Mi00ZTE5LWE3YWMtZjZhNDYyNWZhNDQzLTEyNzUwODEtMjAyNS0wOS0xMC1lbg==/tiny/FibroBiologics-Inc-.png

0 · Reply

MrTicker Sep. 10 at 12:32 PM

$FBLG FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related TherapiesPilot studies have shown encouraging results that are supporting the company’s pre-IND enabling development, marking a critical step toward clinical translation of the Bone Marrow Organoid technology GLOBENEWSWIRE 7:30 AM ET 9/10/2025

0 · Reply

Gemers Sep. 6 at 9:24 PM

$FBLG

0 · Reply

Hassan77 Sep. 5 at 5:00 PM

$FBLG I’m tired of chasing plays and taking L’s. Need a home run and this stock seems to be one of the last bio’s that hasnt gotten any love recently in comparison to others. Would like to see a morning premarket jump to 1.50-2 with news before the end of the year.

1 · Reply

Hassan77 Sep. 5 at 4:56 PM

$FBLG Im stuffing $15K cash in here on Monday with hopes this is the bottom as Ive been watching this stock for months now not really moving up or down and seems to be at a stalemate. Usually in cases like these, could be a 200-300% upwards move ready to happen. Any clinical trial news for CybroCell or any of the other fibro treatments in the pipeline coming soon?

1 · Reply

derider58 Sep. 4 at 1:08 PM

$FBLG

0 · Reply

MrTicker Aug. 28 at 6:57 PM

$FBLG starting to warm up. keep an eye on this during power hour

0 · Reply